Physiologically based pharmacokinetic model for chronic inhalation of 2- butoxyethanol

Toxicology and Applied Pharmacology

Volumn 153, Issue 2, 1998, Pages 211-226

  Lee, Kyeonghee M ^a   Dill, Jeffrey A ^a   Chou, Billy J ^a   Roycroft, Joseph H ^b  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTOXYACETIC ACID; 2 BUTOXYETHANOL; ACETIC ACID DERIVATIVE; SOLVENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL MODEL; BODY COMPOSITION; BODY WEIGHT; CARCINOGENICITY; ENVIRONMENTAL EXPOSURE; FEMALE; HEART OUTPUT; INHALATION; LIVER METABOLISM; LONG TERM EXPOSURE; MALE; METABOLIC CAPACITY; MOUSE; NONHUMAN; PROTEIN BINDING; RAT; SEX DIFFERENCE; SPECIES DIFFERENCE; TOXICOKINETICS; URINARY EXCRETION;

EID: 0032425229     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8518     Document Type: Article

References (59)

1. Aasmoe L., Winberg J. O., Aarbakke J. Gender difference in rat hepatic biotransformation of 2-methoxyethanol, 2-ethoxyethanol and 2-butoxyethanol. Toxicol. Lett. 88:1996;88.
2. Adams J. R., Barrows C. H. Effect of age on PAH accumulation by kidney slices of female rats. J. Gerontol. 18:1963;37-40.
3. Andersen M. E., Clewell H. J. III, Gargas M. L., Smith F. A., Reitz R. H. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87:1987;185-205.
4. Banks Y., Brewster D. W., Birnbaum L. S. Age-related changes in dermal absorption of 2,3,7,8-tetrachlorodibenzo-p. Fundam. Appl. Toxicol. 15:1990;163-173.
5. Beauchene R. E., Fanestil D. D., Barrows C. H. Jr. The effect of age on active transport and sodium-potassium-activated ATPase activity in renal tissue of rats. J. Gerontol. 20:1965;306-310.
6. Bender A. D. The effect of increasing age on the distribution of peripheral blood flow in man. J. Am. Geriatr. Soc. 13:1965;192-198.
7. Birnbaum L. S. Pharmacokinetic basis of age-related changes in sensitivity to toxicants. Annu. Rev. Pharmacol. 31:1991;101-128.
8. Borgoff S. J., Gargas M. L., Andersen M. E., Conolly R. B. Development of a mechanism-based dosimetry model for 2,4,4-trimethyl-2-pentanol-induced α2u-globulin nephorpathy in male Fisher 344 rats. Fundam. Appl. Toxicol. 25:1995;124-137.
9. Carpenter C. P., Pozzani C. U., Weil C. S., Nair H. J., Keck G. A., Smyth H. F. The toxicity of butyl cellosolve solvent. Arch. Ind. Health. 14:1956;114-131.
10. Chou, B. J. Bates, D. J. Decker, J. R. Dill, J. A. Grumbein, S. L. Lee, K. M. Rowe, S. E. Weigel, R. J. Westerberg, R. B. Young, J. Y. 1996a, Two-Year Chronic Inhalation Toxicity and Carcinogenicity Study of 2-Butoxyethanol in F344/N Rats, National Toxicology Program, Research Triangle Park, NC.
11. Chou, B. J. Bates, D. J. Decker, J. R. Dill, J. A. Grumbein, S. L. Lee, K. M. Rowe, S. E. Weigel, R. J. Westerberg, R. B. Young, J. Y. 1996b, Two-Year Chronic Inhalation Toxicity and Carcinogenicity Study of 2-Butoxyethanol in B6C3F1 Mice, National Toxicology Program, Research Triangle Park, NC.
12. Chou, B. J. Bates, S. M. Decker, J. R. Gieschen, A. W. Horstman, M. G. Pierce, J. T. Ragan, H. A. Wagner, A. P. Rowe, S. E. Weigel, R. J. Westerberg, R. B. Young, J. Y. 1992a, 13-Week Subchronic Inhalation Toxicity Study of 2-Butoxyethanol in F344/N Rats, National Toxicology Program, Research Triangle Park, NC.
13. Chou, B. J. Bates, S. M. Decker, J. R. Gieschen, A. W. Horstman, M. G. Pierce, J. T. Ragan, H. A. Wagner, A. P. Rowe, S. E. Weigel, R. J. Westerberg, R. B. Young, J. Y. 1992b, 13-Week Subchronic Inhalation Toxicity Study of 2-Butoxyethanol in B6C3F1 Mice, National Toxicology Program, Research Triangle Park, NC.
14. Coniglio J. J., Liu D. S. H., Richardson A. A comparison of protein synthesis by liver parenchymal cells isolated from Fischer F344 rats of various ages. Mech. Ageing Dev. 11:1979;77-90.
15. Corley R. A., Bormett G. A., Ghanayem B. I. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans. Toxicol. Appl. Pharmacol. 129:1994;6179.
16. Corley R. A., Markham D. A., Bank C., Delorme P., Masterman A., Houle J. M. Physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapor by humans. Fundam. Appl. Toxicol. 39:1997;120-130.
17. Davies B., Morris T. Physiological parameters in laboratory animals and humans. Pharm. Res. 10:1993;1093-1095.
18. Dill J. A., Lee K. M., Bates D. J., Anderson D. J., Johnson R. E., Chou B. J., Roycroft J. H. Toxicokinetics of inhaled 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in F344 rats and B6C3F1 mice. Toxicol. Appl. Pharmacol. 153:1998;227-242.
19. SimuSolv-Modeling and Simulation Language. 1990;Dow Chemical Co. Midland.
20. Fenske N. A., Lober C. W. Structural and functional changes of normal aging skin. J. Am. Acad. Dermatol. 15:1986;571-585.
21. Fisher J. W., Gargas M. L., Allen B. C., Andersen M. E. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. Toxicol. Appl. Pharmacol. 109:1991;183-195.
22. Ghanayem B. I., Blair P. C., Thompson M. B., Maronpot R. R., Matthews H. B. Effect of age on the toxicity and metabolism of ethylene glycol monobutyl ether (2-butoxyethanol) in rats. Toxicol. Appl. Pharmacol. 91:1987;222-234.
23. Ghanayem B. I., Sanders J. M., Clark A. M., Bailer J., Matthews H. B. Effects of dose, age, inhibition of metabolism and elimination on the toxicokinetics of 2-butoxyethanol and its metabolites. J. Pharmacol. Exp. Ther. 253:1990;136-143.
24. Goldstein R. S., Tarloff J. B., Hook J. B. Age-related nephropathy in laboratory rats. FASEB J. 2:1988;2241-2251.
25. Horbach G. J. M. J., Yap S. H., van Bezooijen C. F. A. Age-related changes in albumin elimination in female WAG/Rij rats. Biochem. J. 216:1983;309-315.
26. Johanson G. Physiologically based pharmacokinetic modeling of inhaled 2-butoxyethanol in man. Toxicol. Lett. 34:1986;23-31.
27. Johanson G. Aspects of biological monitoring of exposure to glycol ethers. Toxicol. Lett. 43:1988;5-21.
28. Johanson G. Inhalation toxicokinetics of butoxyethanol and its metabolite butoxyacetic acid in the male Sprague-Dawley rat. Toxicology. 68:1994;588-594.
29. Johanson G., Boman A. Percutaneous absorption of 2-butoxyethanol vapour in human subjects. Br. J. Ind. Med. 48:1991;788-792.
30. Johanson G., Johnsson S. Gas chromatographic determination of butoxyacetic acid in human blood after exposure to 2-butoxyethanol. Arch. Toxicol. 65:1991;433-435.
31. Kenyon E. M., Kraichely R. E., Hudson K. T., Medinsky M. A. Differences in rates of benzene metabolism correlate with observed genotoxicity. Toxicol. Appl. Pharmacol. 136:1996;49-56.
32. Lee, K. M. Dill, J. A. Chou, B, J. 1997, Physiologically-based pharmacokinetic model for 2-butoxyethanol, National Toxicology Program, Research Triangle Park, NC.
33. Leung H.-W. Development and utilization of physiologically based pharmacokinetic models for toxicological applications. J. Toxicol. Environ. Health. 32:1991;247-267.
34. Lin J. H. Species similarities and differences in pharmacokinetics. Drug Metab. Dispos. 23:1995;1008-1022.
35. Lin E. H., Hooke K. F., Yeh K. C., Duggan D. E. Dose-dependent pharmacokinetics of Diflunisal in rats: Dual effects of protein binding and metabolism. J. Pharmacol. Exp. Ther. 235:1985;402-406.
36. Maly I. P., Sasse D. Intraacinar profiles of alcohol dehydrogenase and aldehyde dehydrogenase activities in human liver. Gastroenterology. 101:1991;1716-1723.
37. Mauderly J. L. Effect of age on pulmonary structure and function of immature and adult animals and man. Fed. Proc. 38:1979;173-177.
38. Mauderly J. L. The effect of age on respiratory function of Fischer-344 rats. Exp. Aging Res. 8:1982;31-36.
39. Mordenti J. Men versus beast: Pharamcokinetic scaling in mammals. J. Pharm. Sci. 75:1986;1028-1040.
40. Moslen M. T., Kaphalia L., Balasubramanian H., Yin Y. M., Au W. W. Species differences in testicular and hepatic biotransformation of 2-methoxyethanol. Toxicology. 96:1995;217-224.
41. Novak L. P. Aging, total potassium, fat free mass and cell mass in males and females between the ages of 18 and 85 years. J. Gerontol. 27:1972;438-443.
42. Ramsey J. C., Andersen M. E. A physiologically based description of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73:1984;159-175.
43. Reitz R. H., Gargas M. L., Andersen M. E., Provan W. M., Green T. L. Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model. Toxicol. Appl. Pharmacol. 137:1996;253-267.
44. Rescigno A., Beck J. S. Perspective in pharmacokinetics: The use and abuse of models. J. Pharmacokinet. Biopharm. 15:1987;327-340.
45. Rikans L. E., Moore D. R. Effect of age and sex on allyl alcohol hepatotoxicity in rats: Role of liver alcohol and aldehyde dehydrogenase activities. J. Pharmacol. Exp. Ther. 243:1987;20-26.
46. Rodgers J., Gass G. H. The effect of age on serum proteins in mice. Exp. Gerontol. 18:1983;39-45.
47. Salatka K., Kresge D., Harris L., Edelstein D., Ove P. Rat serum protein changes with age. Exp. Gerontol. 6:1971;25-36.
48. Schmucker D. Age-related changes in drug disposition. Pharm. Rev. 30:1979;445-456.
49. Shyr L. J., Sabourin P. J., Medinsky M. A., Birnbaum L. S., Henderson R. F. Physiologically based modeling of 2-butoxyethanol disposition in rats following different routes of exposure. Environ. Res. 63:1993;202-218.
50. Smolen T. N., Smolen A., van de Kamp J. Developmental profile of hepatic alcohol and aldehyde dehydrogenase activities in long-sleep and short-sleep mice. Alcohol. 7:1990;69-74.
51. Thakur A. K. Commentary on the article of A. Rescigno and J. S. Beck. J. Pharmacokinet. Biopharm. 15:1987;341-344.
52. Tillement J. P., Albengres E., Vrien S. Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins. Eur. J. Drug Metab. Pharmacokinet. 3:1979;123-127.
53. Tyler T. R. Acute and subchronic toxicity of ethylene glycol monobuthyl ether. Environ. Health Perspect. 57:1984;185-191.
54. van Bezooijen C. F. A. Influence of age-related changes in rodent liver morphology and physiology on drug metabolism - A review. Mech. Ageing Dev. 25:1984;1-22.
55. Vestal R. E. Drug use in the elderly: A review of problems and special considerations. Drugs. 16:1978;358-382.
56. Wabner C. L., Chen T. S. Aging changes in renal handling ofp. Am. J. Physiol. 25:1987;R871-R877.
57. Wallace S., Whiting B., Runcie J. Factors affecting drug binding in plasma of elderly patients. Br. J. Clin. Pharmacol. 3:1976;327-330.
58. Wilkinson G. R. Plasma and tissue binding considerations in drug disposition. Drug Metab. Rev. 14:1983;427-465.
59. Yates M. S., Hiley C. R. The effect of age on cardiac output and its distribution in the rat. Experientia. 35:1979;78-79.